News Focus
News Focus
Followers 305
Posts 37115
Boards Moderated 1
Alias Born 11/14/2013

Re: flipper44 post# 720030

Saturday, 09/14/2024 1:02:13 PM

Saturday, September 14, 2024 1:02:13 PM

Post# of 818191
I’d guess NWBO is beyond steps 1 & 2 with one or more BP. One BP has been particularly intertwined with DCVax-l.

“The timeline for a big pharmaceutical company to acquire a pre-revenue biotech firm can vary significantly based on several factors, including the complexity of the deal, regulatory considerations, and the specific circumstances of both companies. Generally, the process can take anywhere from a few months to well over a year.

1. **Initial Discussions (1-3 months)**: After deciding to negotiate, initial discussions around interest, valuations, and strategic fit typically occur.

2. **Due Diligence (2-6 months)**: Once both parties agree to move forward, a thorough due diligence process begins, which involves reviewing financials, intellectual property, and clinical data.

3. **Negotiation and Agreement (1-3 months)**: After due diligence, negotiations regarding the terms of the acquisition take place, which can take additional time.

4. **Regulatory Approval (varies)**: Depending on the size of the acquisition and the jurisdictions involved, regulatory approval may be needed, which can add time.

Overall, it is a multi-stage process that can be affected by the urgency of the acquisition, market conditions, and the specific characteristics of the companies involved.” — chatGPT

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News